Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Ang, C W; Laman, J D; Willison, H J; Wagner, E R; Endtz, H P; De Klerk, M A; Tio-Gillen, A P; Van den Braak, N; Jacobs, B C; Van Doorn, P A

Ang, C W; Laman, J D; Willison, H J; Wagner, E R; Endtz, H P; De Klerk, M A; Tio-Gillen, A P; Van den Braak, N; Jacobs, B C; Van Doorn, P A.

Affiliation

Ang CW; Department of Neurology, Erasmus University/Academic Hospital Dijkzigt Rotterdam, Rotterdam, The Netherlands. Ang@bacl.azr.nl

Infect Immun ; 70(3): 1202-8, 2002 Mar.

Article in En | MEDLINE | ID: mdl-11854201

Subject(s)

Campylobacter jejuni/chemistry; Gangliosides/immunology; Guillain-Barre Syndrome/etiology; Lipopolysaccharides/chemistry; Miller Fisher Syndrome/etiology; Antibodies, Bacterial/blood; Bacterial Typing Techniques; Campylobacter Infections/complications; Campylobacter jejuni/classification; Campylobacter jejuni/immunology; Carbohydrate Sequence; Guillain-Barre Syndrome/microbiology; Humans; Lipopolysaccharides/immunology; Miller Fisher Syndrome/microbiology; Molecular Mimicry; Molecular Sequence Data; Serotyping

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lipopolysaccharides / Campylobacter jejuni / Miller Fisher Syndrome / Guillain-Barre Syndrome / Gangliosides Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Infect Immun Year: 2002 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google